mCPP-induced anxiety--a potential new method for screening anxiolytic activity.
Bilkei-Gorzó
A
A
EGIS Pharmaceuticals Ltd, Budapest, Hungary.
Gyertyán
I
I
Szabados
T
T
D017371:8-Hydroxy-2-(di-n-propylamino)tetralin / Q000627:therapeutic use; D000704:Analysis of Variance; D000818:Animals; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000139:chemically induced / Q000188:drug therapy*; D001569:Benzodiazepines; D003624:Darkness; D008027:Light; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D010879:Piperazines; D051381:Rats; D017208:Rats, Wistar
D014151:Anti-Anxiety Agents; D010879:Piperazines; D001569:Benzodiazepines; D017371:8-Hydroxy-2-(di-n-propylamino)tetralin; C015068:1-(3-chlorophenyl)piperazine